disitamab vedotin
seagen,remegen,rongchang pharma
['bladder', 'disitamab', ' vedo', 'remegen']
$regmy asco 2023: remegen exhibits promising results of disitamab vedotin in bladder cancer 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities